BRIEF published on 10/02/2024 at 15:55, 1 year 2 months ago ZenaTech Receives FAA Approval for ZenaDrone Testing in the US FAA Approval US Market ZenaTech Drone Testing ZenaDrone 1000
PRESS RELEASE published on 10/02/2024 at 15:50, 1 year 2 months ago ZenaTech Announces FAA Approval for Evaluation, Testing, and Demonstration of ZenaDrone Drone Solutions in the US ZenaTech's subsidiary, ZenaDrone, receives FAA approval for testing and demonstrating ZenaDrone drone solutions in the US, enhancing business operations in various sectors FAA Approval US ZenaTech ZenaDrone Drone Solutions
BRIEF published on 09/30/2024 at 13:35, 1 year 2 months ago ZenaTech Granted Approval for Nasdaq Capital Market Listing Nasdaq Direct Listing ZenaTech AI Drones Enterprise SaaS
PRESS RELEASE published on 09/30/2024 at 13:30, 1 year 2 months ago ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market ZenaTech, Inc. announces approval to list common shares on Nasdaq Capital Market, starting trading on Oct 1st. The move is expected to drive company growth and innovation in AI drone and SaaS solutions Common Shares Nasdaq SaaS Solutions ZenaTech AI Drone Solutions
Published on 12/05/2025 at 02:35, 3 hours 23 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 58 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 53 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 58 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 28 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 33 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 43 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 47 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 58 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 13 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 14 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 57 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
